Australia markets closed

WBA May 2024 17.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.01000.0000 (0.00%)
At close: 03:58PM EDT
Full screen
Previous close0.0100
Open0.0100
Bid0.0000
Ask0.0100
Strike17.50
Expiry date2024-05-17
Day's range0.0100 - 0.0300
Contract rangeN/A
Volume341
Open interest16.08k
  • Reuters

    Walgreens launches own brand of opioid overdose reversal drug

    U.S. pharmacy chain operator Walgreens Boots Alliance said on Wednesday it has launched its own brand of popular overdose reversal drug, naloxone, which would be available over-the-counter (OTC). The launch comes weeks after Walgreens' brand was approved by the U.S. Food and Drug Administration in April. Opioid abuse has plagued the United States for more than two decades and killed more than half a million Americans, with fentanyl and synthetic versions being a major culprit in recent years, according to government data.

  • Business Wire

    Walgreens Brand Naloxone Available Online and In Stores This Month

    DEERFIELD, Ill., May 15, 2024--Walgreens today announced it is expanding access to an over the counter, life-saving medication with the launch of Walgreens Brand Naloxone HCI Nasal Spray.

  • Zacks

    Walgreens Boots Alliance (WBA) Outperforms Broader Market: What You Need to Know

    Walgreens Boots Alliance (WBA) closed at $18.35 in the latest trading session, marking a +1.27% move from the prior day.